Nigeria Cardiovascular Diseases Therapeutics Market Analysis

Nigeria Cardiovascular Diseases Therapeutics Market Analysis

$ 3999

Nigeria's cardiovascular disease therapeutics market is projected to grow from $146 Mn in 2022 to $275 Mn in 2030 with a CAGR of 8.22% for the year 2022-30. The growing prevalence of cardiovascular diseases in Nigeria along with various programs implemented by the Nigerian government to promote cardiovascular health are major market drivers. The Nigeria cardiovascular disease therapeutics market is segmented by disease indication, drug type, route of administration, drug classification, mode of purchase, and by end user. Taylek Drugs Company, Adler Products, and Novartis are the major players in the Nigeria cardiovascular disease therapeutics market.

ID: IN10NGPH033 CATEGORY: Pharmaceuticals GEOGRAPHY: Nigeria AUTHOR: Dr. Parul Choudhary

Buy Now

Nigeria Cardiovascular Disease Therapeutics Market Executive Analysis

Nigeria's cardiovascular disease therapeutics market is projected to grow from $146 Mn in 2022 to $275 Mn in 2030 with a CAGR of 8.22% for the year 2022-30. The budget for healthcare went from $600 Mn in 2015 to $2.6 Bn in 2023 with a 339.19% rise. Despite an additional $760 Mn, Nigeria's federal government fails to set aside the suggested 15% of its budget for healthcare. The proposed $2.6 Bn for healthcare in the 2023 national budget, according to an analysis by stakeholders in the health sector, is insufficient for Nigeria to attain Universal Health Coverage (UHC) by 2030. The analysis's main conclusions are: the national budget for health will increase from 4.7% in 2022 to 5.75% in 2023; Family planning (FP) services were scaled up from zero budget in 2022 to $0.04 Mn in 2023 to purchase commodities through counterpart funding, while the Basic Health Care Provision Fund (BHCPF) was reduced by 13.61 % from $120 Mn in 2018 to $100 Mn in the proposed 2023 budget projections.

The latest WHO statistics show that 61,374 deaths from coronary heart disease, or 4.14% of all deaths, occurred in Nigeria in 2020. Nigeria is ranked #107 in the globe by age-adjusted Death Rate, which is 100.91 per 100,000 of the population. The arteries are widened by ACE inhibitors, which reduce blood pressure and facilitate the heart's ability to pump blood. Spironolactone (Aldactone) and eplerenone (Inspra) are examples of the potassium-sparing diuretics drug family. They can reduce the swelling and fluid retention that heart illness can bring about. They assist the kidneys in releasing extra water and sodium from the tissues and blood vessels through the production of urine. Even while receiving other therapies, some symptoms may be relieved by these medications. They shield the heart by preventing the body's aldosterone chemical, which increases fluid and sodium retention. For those with heart failure, angiotensin II receptor blockers (ARBs) are used to reduce blood pressure. They aid in maintaining the widest possible blood arteries, which facilitates easier blood circulation throughout the body. Additionally, they prevent fluid and sodium retention in the body. Beta-blockers obstruct adrenaline's effects. (epinephrine). The heart functions better as a result. These medications also reduce the harmful chemicals your body produces as a result of heart failure. Additionally, they make the heart pulse less forcefully and more slowly. Both of those reduce your blood pressure.

Nigeria Cardiovascular Disease Therapeutics Market Analysis

Market Dynamics

Market Growth Drivers

Due to ageing, urbanization, and changing lifestyles, cardiovascular disease is one of the top causes of death in Nigeria. The need for therapeutics for cardiovascular diseases has increased in the nation as a result of this. The need for preventative measures and treatment options has increased as general awareness of the risks connected with cardiovascular disease has grown. This has resulted in greater funding for therapeutic research and development for cardiovascular diseases. The Nigerian government has launched a number of programs to fight cardiovascular disease, such as facilitating the establishment of specialist clinics and training courses for medical staff. Patients nationwide now have easier access to therapeutics for cardiovascular diseases as a result of this thereby resulting in the expansion of Nigeria's cardiovascular disease therapeutics market.

Market Restraints

The lack of sufficient healthcare infrastructure in Nigeria can restrict access to treatments for cardiovascular disease and other healthcare-related conditions.  Many patients in Nigeria may not be able to afford the expense of cardiovascular disease treatments, especially those without access to health insurance or other forms of financing. This may reduce the expansion of Nigeria's cardiovascular disease therapeutics market. In Nigeria, there is a deficient infrastructure for research and development of therapeutics for cardiovascular disease, which may restrict the development of novel treatments and prevent market innovation.

Competitive Landscape

Key Players

  • New Heights Pharma (NGA)
  • Nestchem Pharmaceuticals (NGA)
  • Drugfield Pharmaceuticals (NGA)
  • Taylek Drugs Company (NGA)
  • Adler Products (NGA)
  • Novartis
  • Relypsa
  • Vectus Biosystems
  • Phasebio Pharmaceuticals
  • Ablative Solutions
  • Mylan
  • Curemark
  • Takeda

Healthcare Policies and Regulatory Landscape

The local Health Maintenance Organization Hygeia Nigeria Ltd. and PharmAccess Foundation are responsible for implementing the Health Insurance Fund (HIF) initiative in Nigeria. Private and municipal clinics have been hired by Hygeia to treat the enrollees. The insurance plan includes basic care and only a small amount of secondary care, and it covers the majority of the medical issues that are most frequently encountered by the target populations. The insurance plan covers treatment for conditions like diabetes and hypertension which are CVD risk factors. Prior to the implementation of the HCHP program, there were no established standards for the treatment of individuals with CVD risk factors.

To enhance insurance coverage and reimbursement practices for cardiovascular disease, the Nigerian government has put in place a number of projects. A government-sponsored program called the National Health Insurance Scheme (NHIS) offers eligible Nigerians health insurance benefits, including coverage for cardiovascular diseases. For eligible patients, the NHIS includes both inpatient and outpatient care, as well as prescription drugs.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company Overview Product Applications and Services Recent Developments Partnerships Ecosystem Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Cardiovascular Disease Therapeutics Segmentation

By Disease Indication (Revenue, USD Billion):

  • Hypertension
  • Coronary Artery Disease
  • Hyperlipidaemia
  • Arrhythmia
  • Others

By Drug Type (Revenue, USD Billion):

  • Antihypertensive
  • Anticoagulants
  • Antihyperlipidemic
  • Antiplatelet Drugs
  • Others

By Route of Administration (Revenue, USD Billion):

  • Oral
  • Parenteral
  • Others

By Drug Classification (Revenue, USD Billion):

  • Branded Drugs
  • Generic Drugs

By Mode of Purchase (Revenue, USD Billion):

  • Prescription-Based Drugs
  • Over-The-Counter Drugs

By End Users (Revenue, USD Billion):

  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
  • Others

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.


Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:



Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.



Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.

We value your inquiry and offer free customization with every report to fulfil your exact research needs.

This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 14 June 2024
Updated by: Keta Vora

Related reports (by category)

Related reports (by geography)

subscribe to our newsletter